Gregory Smith on capital allocation
From Medtronic PLC ($MDT) Q4 2025 Earnings Call · · Castify Earnings Call
“Our preferred path involves two steps. First, we plan to execute an IPO of up to 20% of the diabetes business. The proceeds are expected to appropriately capitalize the new diabetes company and provide the ability to retire Medtronic shares. Second, we intend to execute a spin-off where Medtronic will exchange our remaining new diabetes company shares for Medtronic shares from willing shareholders.”
On , Gregory Smith, Executive Vice President of Enterprise Operations at Medtronic, spoke about capital allocation during Medtronic PLC ($MDT) Q4 2025 Earnings Call on Castify Earnings Call.
About Gregory Smith
During Medtronic's fiscal fourth quarter 2025 earnings call on May 1, 2025, an executive noted that the supply chain team under Gregory Smith, Executive Vice President of Enterprise Operations, "has kicked off a lot of very positive initiatives" and that the company is "starting to see the results" with expectations of further progress. The comment came as part of a broader discussion about margin improvement opportunities.